Work

c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation

Year: 2021
Type: article
Abstract: Carcinogens trigger c-MYC-directed NRF2 activation. Over-activation of NRF2 promotes malignant progression of HNSCC through reprogramming G6PD- and TKT-mediated nucleotide biosynthesis. Targeting NRF2-directed cellular metabolism is an effective strategy for development of novel treatments for head and neck cancer.
Source: Theranostics
Language: English
Open Access status: gold
Estimated APC paid: $1,671
OpenAlex ID: W3136856597
FWCI: 4.905
Cites: 77
Cited by: 122
Related to: 10